Pranil K. Chandra, DO


Director, Molecular Pathology Services and Interim Medical Director, Clinical Pathology of PathGroup.

Authored Items

Molecular Diversity of CLL

June 2014, Vol 3, No 4 - Uncategorized

PMO is pleased to offer the department The Biomarker to discuss the identification of biomarkers in patients with cancer and the prognostic/predictive impact and clinical decision-making implications of that marker. Do you have a unique case to share with our reading community? Please submit your biomarker-driven cases to us at [ Read More ]

KIT Genetic Mutation in a Melanoma Patient

Uncategorized

PMO is pleased to offer the department “The Biomarker” to discuss the identification of biomarkers in patients with cancer and the prognostic/predictive impact and clinical decision-making implications of that marker. Do you have a unique case to share with our reading community? Please submit your biomarker-driven cases to us at [ Read More ]

Sign me up!